Examples of using Randomised study in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
COMFORT-II was an open-label, randomised study in 219 patients.
A three-arm randomised study investigating the combination of everolimus with.
Twenty-one female volunteers(aged 22 to 56 years) with oily andshiny facial skin were enrolled in a controlled, randomised study.
Another randomised study included 66 patients on tacrolimus versus 67 patients on ciclosporin.
Patients with serum creatinine> 1.5 x Upper Limit of the Normal range(ULN)were excluded from the randomised study.
A published randomised study has shown the low-tech and low-cost ancient art of tai chi improves the condition significantly over 12 weeks.
The difference in bioavailability was less marked upon steady-state administration to renal transplant recipients, andtherapeutic equivalence has been demonstrated in a randomised study of 477 patients.
This was a double-blind,placebo-controlled, randomised study in pre-term or term neonates(gestational age 36-42 weeks) with PPHN.
Using the 17-segment model, the number of segments showing a reversible perfusion defect was calculated for the initial adenosine study and for the randomised study obtained using Rapiscan or adenosine.
OASIS 6 was a double blind, randomised study assessing the safety and efficacy of fondaparinux 2.5 mg once daily, versus usual care placebo(47%) or UFH(53%) in approximately 12,000 patients with STEMI.
It is likely that these adverse reactions also occurred in the large randomised study, but they were not recorded because only serious and life- threatening adverse reactions were collected in that study. .
The only randomised study comparing extensive screening with no screening for occult malignancy showed that occult malignancy could be detected at an earlier stage, but provided no clear answer as to whether this was of significance for the prognosis(19).
Submission of the final clinical study report for study 3066K1-4438-WW, a randomised study comparing 2 intravenous temsirolimus regimens in patients with relapsed, refractory Mantle Cell Lymphoma.
In this open-label randomised study with the bosentan 32 mg dispersible tablet formulation, 64 children with stable PAH from 3 months to 11 years of age were randomised to 24 weeks bosentan treatment 2 mg/kg twice daily(n 33) or 2 mg/kg three times daily n 31.
The NEFA study is a controlled prospective randomised study which evaluated treatment options for patients who switch from protease inhibitor(PI) based regimen with undetectable load to either Viramune, efavirenz or abacavir.
EMR 62 202-006: This randomised study compared the combination of cetuximab and radiation therapy(211 patients) with radiation therapy alone(213 patients) in patients with locally advanced squamous cell cancer of the head and neck.
The NEFA study is a controlled prospective randomised study which evaluated treatment options for patients who switch from protease inhibitor(PI) based regimen with undetectable load to either nevirapine, efavirenz or abacavir.
CA225006: This randomised study in patients with metastatic colorectal cancer who had received initial combination treatment with oxaliplatin plus fluoropyrimidine for metastatic disease compared the combination of cetuximab and irinotecan(648 patients) with irinotecan alone 650 patients.
ACTG 5202 study was a, multi-centre,comparative, randomised study of double-blind abacavir/lamivudine or emtricitabine/tenofovir in combination with open-label efavirenz or atazanavir/ritonavir in treatment-naïve HIV-1 infected patients.
In the only randomised study involving a comparison of extensive work-up with no screening with occult malignancy in mind, it was suggested that occult maligancy could be detected at an earlier stage, but there was no clear answer as to whether it was of significance for the prognosis(19).
This study was extended with a 52-week double-blind, randomised study to evaluate the safety, tolerability and efficacy of aliskiren compared to enalapril in 208 paediatric hypertensive patients aged 6 to 17 years at baseline in the previous study. .
A three-arm randomised study investigating the combination of everolimus with exemestane versus everolimus alone versus capecitabine in patients with oestrogen-receptor positive metastatic breast cancer after recurrence or progression on letrozole or anastrozole based on a CHMP approved protocol.
The purpose of the third multicentre, double-blind, randomised study was the assessment of efficacy and safety of 0.03% tacrolimus ointment applied once or twice a day relative to twice daily administration of 1% hydrocortisone acetate ointment in children with moderate to severe atopic dermatitis.
EMR 62 202-007: This randomised study in patients with metastatic colorectal cancer after failure of irinotecan-based treatment for metastatic disease as the last treatment before study entry compared the combination of cetuximab and irinotecan(218 patients) with cetuximab monotherapy 111 patients.
Prophylaxis of influenza in immunocompromised patients: A double-blind,placebo-controlled, randomised study was conducted for seasonal prophylaxis of influenza in 475 immunocompromised patients(388 patients with solid organ transplantation[195 placebo; 193 oseltamivir], 87 patients with haemopoetic stem cell transplantation[43 placebo; 44 oseltamivir], no patient with other immunosuppressant conditions), including 18 children 1 to 12 years of age.
In a large controlled randomised study, mifamurtide used at the recommended dose and schedule with other medicinal products that have known renal(cisplatin, ifosfamide) or hepatic(high-dose methotrexate, ifosfamide) toxicities did not exacerbate those toxicities and there was no need to adjust mifamurtide dose.
A phase III,multicentre, randomised study was conducted to evaluate the safety and efficacy of different dose levels of Signifor over a twelve-month treatment period in Cushing's disease patients with persistent or recurrent disease or de novo patients for whom surgery was not indicated or who refused surgery.
CA225025: This randomised study in patients with metastatic colorectal cancer who had received prior oxaliplatin-, irinotecan- and fluoropyrimidine-based treatment for metastatic disease compared the addition of cetuximab as a single agent to best supportive care(BSC)(287 patients) with best supportive care 285 patients.
In an open-label randomised study, there were no statistically significant differences between adult patients treated for 52 weeks with 0.2 mg/kg intravenously every other week(n=20) and those treated with 0.2 mg/kg weekly(n=19) in mean change from baseline LVMI or other endpoints cardiac functional status, renal function, and pharmacodynamic activity.
Not only for randomised studies or pharmaceutical drug studies, but also for.